In some countries, where the health crisis for the new coronavirus is at its peak, others will see the worst in the coming weeks,media reported. The only thing people can do now is wait for the blockade to take effect. Social alienation flattens the curve, giving hospitals and governments much-needed breathing space.
But once the number of people infected per day drops significantly, the battle with the new coronavirus will be hard to end. This means that humans must eradicate it or it could become a seasonal disease like influenza, and it is much more contagious and deadly than the latter.
There are two ways to get immunity, but neither is easy. Vaccines will not be available for at least the next 12 to 18 months, and researchers hope they will work. Fortunately, the virus has not yet had a major mutation. All people can do before the vaccine arrives is to wait and hope they don’t get infected until then. Another approach is to fight the new coronavirus directly, but this method is best based on a mild infection. While there are no specific treatments available to help strengthen the immune system’s battle with pathogens, there are several promising treatments being tested in many hospitals treating patients with new coronaviruses. Researchers from Australia have just discovered a new drug that could kill the SARS-CoV-2 virus. The drug works well and can remove any traces of the virus in two days, but it is only the result of laboratory tests.
The drug is called ivermectin, but it’s best not to use it unless it accelerates the recovery of the new coronavirus. This is because the drug was developed in the mid-1970s to fight head lice, scabies and other diseases caused by parasites such as ticks and whipworms. In addition, the drug is also suitable for onchocerciasis or river blindness, patients will experience severe itching, lumps under the skin, and blindness. At the same time, ivermectin can also kill larvae and adult strains, which need to be taken every 6 to 12 months. It is also reported to be used in the treatment of AIDS, dengue and Zika viruses. This may be why researchers are also trying to use it against the SARS-CoV-2 virus.
A team of scientists from Monash University’s Institute of Biomedical Discovery (BDI) and the Peter Doherty Institute for Infection and Immunity concluded that the drug may form the basis of the new coronavirus vaccine.
Dr. Kylie Wagstaff of BDI said of the drug that they found that even a single dose of the drug could remove all viral RNA within 48 hours, and that even within 24 hours, the content of viral RNA could be significantly reduced. But the doctor cautioned that current trials are conducted only in vitro and that it will require actual human trials to prove the findings. “Evicoin is widely used and is considered a safe drug. What we need to figure out now is whether the dose you can use on the human body is effective, and that’s the next step. “
It is unclear when or if the Ivico test will begin in patients with new coronary pneumonia.